PBI-100

N/A

Report date: 2026/05/03 20:00:15
NME

Base Information

Drug NamePBI-100
Drug Alias NamePBI-100
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTropomyosin-related kinase modulators
TargetsTropomyosin-related kinase
Therapy Area/IndicationsPsoriasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPyramid Biosciences
China Registration ClassN/A

Develop Information

Active CompaniesPyramid Biosciences
Inactive CompaniesN/A
Active IndicationsPsoriasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A